Inhibrx Capital Lease Obligations vs Total Current Liabilities Analysis

INBX Stock  USD 21.60  0.32  1.46%   
Inhibrx Biosciences, financial indicator trend analysis is infinitely more than just investigating Inhibrx Biosciences, recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Inhibrx Biosciences, is a good investment. Please check the relationship between Inhibrx Biosciences, Capital Lease Obligations and its Total Current Liabilities accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inhibrx Biosciences,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Inhibrx Stock please use our How to Invest in Inhibrx Biosciences, guide.

Capital Lease Obligations vs Total Current Liabilities

Capital Lease Obligations vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Inhibrx Biosciences, Capital Lease Obligations account and Total Current Liabilities. At this time, the significance of the direction appears to have no relationship.
The correlation between Inhibrx Biosciences,'s Capital Lease Obligations and Total Current Liabilities is 0.03. Overlapping area represents the amount of variation of Capital Lease Obligations that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Inhibrx Biosciences,, assuming nothing else is changed. The correlation between historical values of Inhibrx Biosciences,'s Capital Lease Obligations and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Lease Obligations of Inhibrx Biosciences, are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Capital Lease Obligations i.e., Inhibrx Biosciences,'s Capital Lease Obligations and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

0.03
Relationship DirectionPositive 
Relationship StrengthInsignificant

Capital Lease Obligations

Inhibrx Biosciences, capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Inhibrx Biosciences, asset purchases. For example, Inhibrx Biosciences, can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Inhibrx Biosciences, control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.

Total Current Liabilities

Total Current Liabilities is an item on Inhibrx Biosciences, balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Inhibrx Biosciences, are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Inhibrx Biosciences,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Inhibrx Biosciences, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inhibrx Biosciences,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Inhibrx Stock please use our How to Invest in Inhibrx Biosciences, guide.At this time, Inhibrx Biosciences,'s Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to 2,133 in 2025, whereas Issuance Of Capital Stock is likely to drop 0.00 in 2025.
 2022 2023 2024 2025 (projected)
Total Operating Expenses131.3M219.8M331.6M348.2M
Cost Of Revenue2.8M1.2M2.3M2.2M

Inhibrx Biosciences, fundamental ratios Correlations

0.830.910.870.670.7-0.74-0.920.651.00.751.00.110.750.270.831.0-0.51-0.58-0.36-0.170.980.460.34-0.060.66
0.830.680.620.190.35-0.24-0.930.290.840.380.840.580.960.070.950.84-0.07-0.33-0.20.020.840.040.66-0.50.42
0.910.680.960.640.73-0.73-0.860.670.890.80.89-0.020.630.220.740.9-0.45-0.54-0.27-0.110.910.550.180.020.87
0.870.620.960.60.85-0.73-0.830.810.850.880.85-0.120.620.350.740.86-0.48-0.41-0.29-0.240.870.470.150.030.81
0.670.190.640.60.57-0.97-0.40.610.670.640.67-0.420.030.330.170.66-0.8-0.71-0.3-0.270.650.78-0.190.470.57
0.70.350.730.850.57-0.72-0.560.850.660.970.66-0.340.410.440.530.67-0.69-0.09-0.43-0.370.640.38-0.10.310.51
-0.74-0.24-0.73-0.73-0.97-0.720.47-0.74-0.72-0.79-0.720.48-0.14-0.37-0.29-0.720.790.650.390.3-0.69-0.780.21-0.48-0.63
-0.92-0.93-0.86-0.83-0.4-0.560.47-0.54-0.92-0.58-0.92-0.39-0.88-0.18-0.93-0.930.260.430.110.07-0.96-0.22-0.560.4-0.67
0.650.290.670.810.610.85-0.74-0.540.630.830.63-0.40.310.660.440.63-0.68-0.3-0.15-0.590.620.290.120.170.45
1.00.840.890.850.670.66-0.72-0.920.630.711.00.140.760.270.831.0-0.5-0.6-0.35-0.170.980.450.36-0.080.64
0.750.380.80.880.640.97-0.79-0.580.830.710.71-0.390.420.330.550.72-0.67-0.25-0.47-0.240.680.52-0.150.40.59
1.00.840.890.850.670.66-0.72-0.920.631.00.710.140.760.270.831.0-0.5-0.6-0.35-0.170.980.450.36-0.080.64
0.110.58-0.02-0.12-0.42-0.340.48-0.39-0.40.14-0.390.140.53-0.270.430.140.370.150.340.30.21-0.460.68-0.84-0.04
0.750.960.630.620.030.41-0.14-0.880.310.760.420.760.530.030.980.760.05-0.16-0.250.050.74-0.040.59-0.510.36
0.270.070.220.350.330.44-0.37-0.180.660.270.330.27-0.270.030.10.26-0.540.04-0.03-0.990.26-0.220.3-0.060.0
0.830.950.740.740.170.53-0.29-0.930.440.830.550.830.430.980.10.84-0.07-0.23-0.290.00.820.080.53-0.420.49
1.00.840.90.860.660.67-0.72-0.930.631.00.721.00.140.760.260.84-0.49-0.59-0.34-0.160.980.450.36-0.090.65
-0.51-0.07-0.45-0.48-0.8-0.690.790.26-0.68-0.5-0.67-0.50.370.05-0.54-0.07-0.490.280.150.51-0.49-0.380.08-0.46-0.25
-0.58-0.33-0.54-0.41-0.71-0.090.650.43-0.3-0.6-0.25-0.60.15-0.160.04-0.23-0.590.280.05-0.09-0.57-0.7-0.1-0.17-0.53
-0.36-0.2-0.27-0.29-0.3-0.430.390.11-0.15-0.35-0.47-0.350.34-0.25-0.03-0.29-0.340.150.050.03-0.19-0.420.44-0.48-0.08
-0.170.02-0.11-0.24-0.27-0.370.30.07-0.59-0.17-0.24-0.170.30.05-0.990.0-0.160.51-0.090.03-0.150.27-0.260.030.1
0.980.840.910.870.650.64-0.69-0.960.620.980.680.980.210.740.260.820.98-0.49-0.57-0.19-0.150.420.41-0.190.72
0.460.040.550.470.780.38-0.78-0.220.290.450.520.45-0.46-0.04-0.220.080.45-0.38-0.7-0.420.270.42-0.560.60.67
0.340.660.180.15-0.19-0.10.21-0.560.120.36-0.150.360.680.590.30.530.360.08-0.10.44-0.260.41-0.56-0.8-0.05
-0.06-0.50.020.030.470.31-0.480.40.17-0.080.4-0.08-0.84-0.51-0.06-0.42-0.09-0.46-0.17-0.480.03-0.190.6-0.80.01
0.660.420.870.810.570.51-0.63-0.670.450.640.590.64-0.040.360.00.490.65-0.25-0.53-0.080.10.720.67-0.050.01
Click cells to compare fundamentals

Inhibrx Biosciences, Account Relationship Matchups

Inhibrx Biosciences, fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets143.7M150.5M290.9M307.9M180.8M140.4M
Short Long Term Debt Total37.5M70.5M202.1M210.1M8.0M7.6M
Other Current Liab13.4M9.6M19.3M43.9M29.9M15.2M
Total Current Liabilities31.4M22.5M27.6M56.3M40.7M28.0M
Total Stockholder Equity75.5M52.4M58.1M43.5M133.6M140.3M
Property Plant And Equipment Net11.3M9.5M7.2M9.4M13.5M8.2M
Net Debt(91.2M)(60.8M)(71.8M)(67.8M)(144.5M)(137.3M)
Retained Earnings(145.4M)(227.1M)(372.4M)(613.7M)(106.1M)(111.4M)
Accounts Payable13.5M9.1M4.3M8.3M9.2M6.7M
Cash128.7M131.3M273.9M277.9M152.6M123.6M
Non Current Assets Total11.6M11.3M10.4M12.5M20.4M10.3M
Cash And Short Term Investments128.7M131.3M273.9M277.9M152.6M123.6M
Common Stock Shares Outstanding25.3M38.0M40.1M47.1M14.5M26.1M
Liabilities And Stockholders Equity143.7M150.5M290.9M307.9M180.8M140.4M
Non Current Liabilities Total36.9M75.6M205.2M208.1M6.5M6.1M
Other Current Assets132.2M7.8M5.5M16.7M6.9M6.6M
Total Liab68.3M98.1M232.8M264.4M47.2M44.8M
Total Current Assets132.2M139.1M280.5M295.4M160.4M130.1M
Short Term Debt1.5M1.7M3.7M4.1M1.6M2.9M
Current Deferred Revenue7.9M3.1M2.0M166K149.4K141.9K
Net Receivables615K878K257K778K420K477.2K
Inventory3.2M(129.3M)(878K)(257K)(231.3K)(242.9K)
Other Stockholder Equity220.8M279.5M430.4M657.2M239.7M236.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Inhibrx Stock Analysis

When running Inhibrx Biosciences,'s price analysis, check to measure Inhibrx Biosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx Biosciences, is operating at the current time. Most of Inhibrx Biosciences,'s value examination focuses on studying past and present price action to predict the probability of Inhibrx Biosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx Biosciences,'s price. Additionally, you may evaluate how the addition of Inhibrx Biosciences, to your portfolios can decrease your overall portfolio volatility.